Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Dexlansoprazole Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102731478A details a high-yield asymmetric oxidation route for Dexlansoprazole intermediates, offering superior optical purity and scalable manufacturing capabilities for global supply chains.
Patent CN102731478A details a high-yield asymmetric oxidation route for Dexlansoprazole intermediates, offering superior optical purity and scalable manufacturing solutions.